Anticipation builds as Insmed bronchiectasis therapy brensocatib nears Phase III completion:…
Brensocatib is a dipeptidyl peptidase-1 (DPP-1) reversible inhibitor which exhibits anti-inflammatory action through suppressing…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.